New Stroke Drug from ZZ Biotech Produced by Laureate... ( PRINCETON N.J. Aug. 13 2012 /- L...)

New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma

Date:8/13/2012

PRINCETON, N.J., Aug. 13, 2012 /PRNewswire/ -- Laureate Biopharma is pleased to announce its successful collaboration with its client, ZZ Biotech, on process development and production of a new potential therapeutic for ischemic stroke. The drug, known as 3K3A-APC, is a form of activated human Protein C whose molecular structure has been intentionally modified to remove the undesirable side effect of bleeding. ZZ Biotech recently announced the start of Phase 1 trials with this material.

(Logo: http://photos.prnewswire.com/prnh/20120214/PH53290LOGO )

Protein C becomes an active protease upon enzymatic activation, a step that is carried out during the purification process. Once activated, this protease can degrade itself, since enzymes are also proteins. Additional complexity arises from the production of isoforms as well as modified amino-acid structures that are important to the activity of 3K3A-APC. Working together with scientists from ZZ Biotech and its collaborators, Laureate's scientists were relentless in overcoming these challenges to produce clinical-trial material.

Kent E. Pryor, Ph.D., Chief Operating Officer of ZZ Biotech said, "We are pleased to have been able to take a difficult protein out of the research lab and put it into the clinic. Our partnership with Laureate has been integral to turning an idea into a potential new human therapeutic."

"This project showcased Laureate's scientific expertise in developing suitable processes for clinical production of challenging proteins," noted Michiel E. Ultee, Ph.D., Laureate's Chief Scientific Officer. "We have successfully produced many fusion proteins, IgM antibodies, and other complex recombinant proteins for our clients to evaluate in the clinic."

Professor John H. Griffin, Ph.D., of The Scripps Research Institute and UCSD, and discoverer of 3K3A-APC, added, "During the development of the proce
'/>"/>

SOURCE Laureate Biopharma
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Masimos Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery
2. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
3. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
4. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
5. German-based Contract Research Organization Verum.de Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech
6. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
7. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
8. Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities
9. Lifeline Biotechnologies First Warning Systems
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, ... American healthcare company providing services in ... Family Healthcare, a network of private hospitals and ... of its Beijing United Family Rehabilitation Hospital ("BJU ... of the United Family Healthcare ("UFH") network. On ...

(Date:6/19/2013)... , June 19, 2013 DST Health Solutions, ... services to health plans, integrated delivery systems, and health ... Medical Drug Management Service (MDMS) has jumped significantly. ... and automate the pricing of medical prescription drug claims, ... by automating their medical drug claims processes. As specialty ...

Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3

[0] BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research [0] Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital [0] Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase

... FARMINGDALE, N.Y., Feb. 9, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative, therapeutic, ... neurosurgery, laparoscopic surgery, and other surgical and medical ... fiscal quarter and six months ending December 31, ...

... SAN FRANCISCO, Feb. 9, 2011 SYNARC, ... to the pharmaceutical and biotechnology industries, announced today that ... and marketing efforts in support of the company,s rapidly ... Ciaran Cooper, a pioneer in the clinical trials ...

Cached Medicine Technology:Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 2 Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 3 Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 4 Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 5 Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 6 SYNARC Appoints Ciaran Cooper as Vice President, Business Development 2

Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results SYNARC Appoints Ciaran Cooper as Vice President, Business Development

(Date:6/19/2013)... (PRWEB) June 19, 2013 ... of neurologists, neurosurgeons, psychiatrists and urologists with specialists ... The team works with patients and their family ... overall quality of life. Patients also have the ... trials and research. , “Movement disorders can be ...

(Date:6/19/2013)... YOKOHAMA, Japan Leading Japanese pharmaceutical companies, along ... Melinda Gates Foundation, pledged their commitment to bolster ... Health Innovative Technology Fund (GHIT Fund), at a ... the fifth Tokyo International Conference on African Development ... partners including the Ministry of Health, Labour ...

(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...

(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...

(Date:6/19/2013)... City, MO (PRWEB) June 19, 2013 Kansas City ... part of Main Street Day . A section of Main ... pedestrian traffic during the afternoon of the event. The Main ... host the event, which will help Kansas City join the ranks ... used Ciclovia as a tool to foster community vibrancy and active ...

Breaking Medicine News(10 mins):Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2 Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2 Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3 Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3

[0] Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center [0] GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health [0] Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers [0] Brightree Debuts on List of Top 100 Healthcare Technology Companies [0] Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia

... access to medical product company,s industry-leading, non-invasive temperature therapy ... ... Tenn., May 29 Adroit Medical Systems, Inc.,today announced its award ... agreement centers on Adroit,s leading,Soft-Temp(R) hypo-hyperthermia blankets, localized heat therapy and ...

... Participating in Outdoor Activities, OFF!(R) Finds ... Uninterrupted, and Your ... sure do know how to make,the most out of their ... their families plan to attend a barbeque,(73 percent), watch fireworks ...

... ... Treatments, LAS ... and marketer of laser, light, and radiofrequency based,aesthetic devices, announced today ... platform for multiple aesthetic laser and,light treatments. The Harmony(XL) can be ...

... May 29 Darwin (NYSE: DR ),is ... product-centric underwriting,divisions, the health care division and the ... ), Under the leadership of senior ... newly created health care division combines all,of Darwin,s ...

... and complex condition that impacts about 15% of the ... known about the mechanisms behind the psychiatric disorder. ... parallels between depressive symptoms and the symptoms of certain ... in Molecular Psychiatry, researchers from University of Miami found ...

... to Cover ... Lost Income, NEW YORK, ... that U.S. employees are just,as concerned about the possibility of losing their ... to a recent survey,from Berkshire Life Insurance Company of America (Berkshire), a,wholly-owned ...

Adroit Medical Systems Awarded Premier Supplier Contract for Temperature Therapy Systems Keep Your Cool and Sanity This Summer!Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008 Darwin Announces Creation of New Health Care and Errors and Omissions Divisions Inflammation, depression and antidepressant response: Common mechanisms Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability

Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 50 OD...

Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...

Polyester ribbons (3) impregnated with different OD values of conjugated Protein A...

Polyester ribbon impregnated with conjugated Protein A - .13 OD per sq. cm....

Medicine Products:

Goat Anti-Human IgG (H & L) Antibody, Colloidal Gold Conjugated, 50 OD Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD Protein A Sample Pack - .13 OD ; .25 OD; .50 OD per sq. cm Protein A, Gold Ribbon - .13 OD per sq. cm.